Saturday 30 April 2016

Sacral Nerve Stimulation Coverage Guidance


Sacral nerve stimulation is defined as the implantation of a permanent device that modulates the neural pathways controlling bladder function. This treatment is one of several alternative modalities for patients with urge urinary incontinence whose incontinence has been refractory to behavioral and pharmacologic treatment.

This treatment involves electrical stimulation of the sacral nerves in the lower region of the spine via a totally implantable system. System components include a lead, an implantable pulse generator and an extension that connects the lead to the pulse generator. It is expected that the physician performing this service has completed a training course in the use and implantation of the device.

Sacral nerve stimulation is covered for the following indications and limitations under CMS National Coverage Determination 230.18:

Indications:
•    Urinary urge incontinence.
•    Urgency-frequency syndrome.
•    Urinary retention.
Sacral nerve stimulation involves both a temporary test stimulation to determine if an implantable stimulator would be effective and if a permanent implantation is appropriate for candidates. Both the test and the permanent implantation are covered.

Limitations:
•    Patient must be refractory to conventional therapy (documented behavioral, pharmacologic and/or surgical corrective therapy) and be an appropriate surgical candidate such that implantation with anesthesia can occur.
•    Patients with stress incontinence, urinary obstruction or specific neurologic disease (e.g., diabetes with peripheral nerve involvement) with associated secondary manifestations of the above indications are excluded from coverage for test stimulation and permanent implantation of sacral nerve stimulation.
•    Patient must have had a successful test stimulation in order to support subsequent implantation. Before a patient is eligible for permanent implantation, he/she must demonstrate a 50% or greater improvement through test stimulation. Improvement is measured through voiding diaries.

Wednesday 27 April 2016

Medicare HMO annual visit CPT code G0402, G0438 and G0439 coverage


Medicare Advantage Program  Coding for Welcome to Medicare and Annual Wellness Visits


IMPORTANT REMINDER: Florida Blue, as a Medicare Advantage plan with four contracts with the Centers for Medicare & Medicaid Services (CMS), reminds you that Medicare Advantage Members are eligible for one Welcome to Medicare visit as well as an Annual Wellness visit. When filing these Medicare Advantage visit claims, it is important for you to use the correct procedure codes r to avoid claim denials.

• G0402 - Initial Preventive Physical Examination (IPPE) or Welcome to Medicare Visit
• G0438 - Annual Wellness Visit (AWV); includes a personalized prevention plan (PPPS)
• G0439 - Subsequent Annual Wellness Visit (AWV); includes a personalized prevention plan (PPPS)

Also, please refer to the bulletin of February 2015, Update: Medicare Advantage Program Coding for Annual Wellness Visits .

Saturday 23 April 2016

Group 1 Codes


289.81    PRIMARY HYPERCOAGULABLE STATE
289.82    SECONDARY HYPERCOAGULABLE STATE
415.11    IATROGENIC PULMONARY EMBOLISM AND INFARCTION
415.12    SEPTIC PULMONARY EMBOLISM
415.13    SADDLE EMBOLUS OF PULMONARY ARTERY
415.19    OTHER PULMONARY EMBOLISM AND INFARCTION
444.9*    EMBOLISM AND THROMBOSIS OF UNSPECIFIED ARTERY
451.0    PHLEBITIS AND THROMBOPHLEBITIS OF SUPERFICIAL VESSELS OF LOWER EXTREMITIES
451.11    PHLEBITIS AND THROMBOPHLEBITIS OF FEMORAL VEIN (DEEP) (SUPERFICIAL)
451.19    PHLEBITIS AND THROMBOPHLEBITIS OF OTHER
451.2    PHLEBITIS AND THROMBOPHLEBITIS OF LOWER EXTREMITIES UNSPECIFIED
451.81    PHLEBITIS AND THROMBOPHLEBITIS OF ILIAC VEIN
451.82    PHLEBITIS AND THROMBOPHLEBOTIS OF SUPERFICIAL VEINS OF UPPER EXTREMITIES
451.83    PHLEBITIS AND THROMBOPHLEBITIS OF DEEP VEINS OF UPPER EXTREMITIES
451.84    PHLEBITIS AND THROMBOPHLEBITIS OF UPPER EXTREMITIES UNSPECIFIED
451.89    PHLEBITIS AND THROMBOPHLEBITIS OF OTHER SITES
451.9    PHLEBITIS AND THROMBOPHLEBITIS OF UNSPECIFIED SITE
452    PORTAL VEIN THROMBOSIS
453.1    THROMBOPHLEBITIS MIGRANS
453.2    OTHER VENOUS EMBOLISM AND THROMBOSIS OF INFERIOR VENA CAVA
453.40    ACUTE VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS OF LOWER EXTREMITY
453.41    ACUTE VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL LOWER EXTREMITY
453.42    ACUTE VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL LOWER EXTREMITY
453.50    CHRONIC VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS OF LOWER EXTREMITY
453.51    CHRONIC VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL LOWER EXTREMITY
453.52    CHRONIC VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL LOWER EXTREMITY
453.6    VENOUS EMBOLISM AND THROMBOSIS OF SUPERFICIAL VESSELS OF LOWER EXTREMITY
453.71    CHRONIC VENOUS EMBOLISM AND THROMBOSIS OF SUPERFICIAL VEINS OF UPPER EXTREMITY
453.72    CHRONIC VENOUS EMBOLISM AND THROMBOSIS OF DEEP VEINS OF UPPER EXTREMITY

Wednesday 20 April 2016

CPT code 93965, 93970, 93971 and G0365 AND covered DX

Non-Invasive Peripheral Venous Studies Coding Information

Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.



11x    Hospital Inpatient (Including Medicare Part A)
12x    Hospital Inpatient (Medicare Part B only)
13x    Hospital Outpatient
18x    Hospital - Swing Beds
21x    Skilled Nursing - Inpatient (Including Medicare Part A)
22x    Skilled Nursing - Inpatient (Medicare Part B only)
23x    Skilled Nursing - Outpatient
28x    Skilled Nursing - Swing Beds
83x    Ambulatory Surgery Center
85x    Critical Access Hospital



Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

The contractor has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this LCD. Providers are reminded that not all CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS Internet-Only Manual (IOM) Pub. 100-04, Claims Processing Manual, for further guidance.



0921    Other Diagnostic Services - Peripheral Vascular Lab

CPT/HCPCS Codes


Group 1 Paragraph

Note: Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book.

Group 1 Codes

93965    Extremity study
93970    Extremity study
93971    Extremity study
G0365    Vessel mapping hemo access
ICD-9 Codes that Support Medical Necessity


Group 1 Paragraph : It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-9-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

Non-Invasive Venous Studies cpt - 93965, 93970, 93971 & G0365 - Payment Guide
Procedure CODE and Description

93965 - Noninvasive physiologic studies of extremity veins, complete bilateral study (eg, Doppler waveform analysis with responses to compression and other maneuvers, phleborheography, impedance plethysmography)


93970 - Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study


93971 - Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study


G0365 - Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)

Indications for venous examinations are separated into three major categories:


  • New-onset deep vein thrombosis.
  • Chronic venous insufficiency.
  • Preoperative venous mapping
Note: Venous studies are medically necessary only if the patient is a candidate for anticoagulation or invasive therapeutic procedures.

Acute Deep Vein Thrombosis (DVT)

New-onset Deep Vein Thrombosis (DVT) is a common vascular complication developing in hospitalized or otherwise immobilized patients and in persons with hypercoaguable states. Because the signs and/or symptoms of acute DVT may be relatively non-specific, objective testing may be necessary for patients who are candidates for anticoagulation or invasive therapeutic procedures and who have one of the following:

  • Exhibit clinical signs and/or symptoms of acute or new-onset DVT such as extremity swelling, tenderness, inflammation and/or erythema.
  • Require investigation for DVT as the source of the pulmonary embolus.
  • Unexplained lower extremity edema with high pretest probability of DVT (e.g., status post-major surgical procedure or postpartum).
Bilateral limb edema, especially when signs and/or symptoms of congestive heart failure, exogenous obesity and/or arthritis are present, should rarely be an indication for venous studies.
The following is a list of procedures considered reasonable for Medicare reimbursement for the evaluation of new-onset DVT:

  • Duplex scan (93970 or 93971).
  • Doppler waveform analysis including responses to compression and other maneuvers (93965).
  • Impedance plethysmography (93965).
  • Air plethysmography (93965).
  • Strain gauge plethysmography (93965).

Chronic Venous Insufficiency
Chronic venous insufficiency may be divided into three categories:
  • Primary varicose veins.
  • Secondary varicose veins.
  • Post-thrombotic (post-phlebitic) syndrome.
It is not medically necessary to study asymptomatic varicose veins. Objective tests of venous function may be indicated in patients with ulceration, thickening and discoloration suspected to be secondary to venous insufficiency to confirm the presence of venous valvular incompetence to determine appropriate treatment. Duplex scanning and physiological tests of extremity veins during the same encounter are not reasonable and medically necessary.
Evaluation of post-thrombotic syndrome is medically necessary when there is evidence of acute change in the involved extremity and recurrent DVT is clinically suspected. Frequency of follow-up studies will be carefully monitored for reasonableness and medical necessity.

Preoperative Venous Mapping
Preoperative vein mapping may be covered when necessary to provide information to the surgeon on suitability of veins to be used in the following circumstances:
  • In preparation for vein harvesting for Coronary Artery Bypass Graft (CABG) surgery and for peripheral bypass graft surgery.
  • In preparation for AV fistula placement for hemodialysis access in patients with end stage renal disease.

Non-invasive peripheral venous studies are covered by Medicare when provided in the following places of service:
  • Physician’s office and physician-directed clinic.
  • Outpatient and inpatient hospital.
  • Nursing facilities.
  • Other facilities such as Independent Diagnostic Testing Facilities (IDTFs).

Note: “Mobile” units are not an appropriate place of service for non-invasive peripheral venous studies.
Vascular diagnostic studies may be personally performed by a physician or technologist. The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill and experience of the technologist and physician performing and interpreting the study. 

Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training through recent residency training or post-graduate Continuing Medical Education (CME) and experience and maintain that documentation for postpayment review.

All non-invasive vascular diagnostic studies, when performed by a technologist, must be performed by a technologist who has demonstrated competency in ultrasound by receiving one of the following credentials in vascular ultrasound technology:

  • Registered Vascular Specialist (RVS) provided by Cardiovascular Credentialing International (CCI).
  • Registered Vascular Technologist (RVT) provided by the American Registry of Diagnostic Medical Sonographers (ARDMS).
  • Vascular Sonographer (VS) provided by the American Registry of Radiologic Technologists, Sonography (ARRT)(S).
Alternately, such studies must be performed in a facility or vascular laboratory accredited by one of the following nationally recognized accreditation organizations:

  • American College of Radiology (ACR) Vascular Ultrasound Accreditation Program.
  • Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL).

If a vascular laboratory or facility is accredited, the technologists performing non-invasive peripheral venous studies in that laboratory are considered to have demonstrated competency in vascular ultrasound.
For areas already within TrailBlazer jurisdiction, these credentialing requirements remain unchanged. Otherwise, the effective date for the credentialing requirement is 12/31/2009.
 Contractors shall consider a service to be reasonable and necessary if the contractor determines that the service is:
  • Safe and effective.
  • Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
  • Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
    • Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
    • Furnished in a setting appropriate to the patient’s medical needs and condition.
    • Ordered and furnished by qualified personnel.
    • One that meets, but does not exceed, the patient’s medical need.
    • At least as beneficial as an existing and available medically appropriate alternative.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.
12X, 13X, 18X, 21X, 22X, 23X, 71X, 83X, 85X

Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.
CPT/HCPCS Codes
Note:
Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book. The American Medical Association (AMA) and the Centers for Medicare & Medicaid Services (CMS) require the use of short CPT descriptors in policies published on the Web.
93965©
Extremity study - Fee schedule amount - $118.22
93970©
Extremity study Fee schedule amount - $183.16
93971©
Extremity study Fee schedule amount - $119.18
G0365
Vessel mapping hemo access Fee schedule amount - $160.14
Billing and Coding Guide for CPT 93970 AND 93971

CPT®93970 Duplex scan of extremity veins, including responses to compression and other maneuvers; complete bilateral study 


** Use for duplex study of extracranial veins such as jugular veins


 CPT®93971 Duplex scan of extremity veins, including responses to compression and other maneuvers; unilateral or limited study


** Use for duplex study of extracranial vein such as jugular vein


Any combination of 93880, 93882 with 93970, 93971, 93925 and 93926 will result in denial of all claims even if otherwise within LCD identified ICD parameters for medical necessity


 All denied claims must be appealed for medical review 


Billing for monitoring of hemodialysis access using CPT codes for noninvasive vascular studies other than 93990 is considered a misrepresentation of the service actually provided and contractors will consider this action for fraud investigation. They will conduct data analysis on a periodic basis for noninvasive diagnostic studies of the extremities (including CPT codes 93922, 93923, 93924, 93925, 93926, 93930, 93931, 93965, 93970, 93971). Contractors should handle aberrant findings under normal program safeguard processes by taking whatever corrective action is deemed necessary


Do not report 36475, 36476 in conjunction with 36000-36005, 36410, 36425, 36478, 36479, 38204, 75895, 76000, 76001, 76937, 76942, 76998, 77022, 93970, 93971.


 In addition, it is not appropriate to bill for extremity venous duplex imaging (93970 – 93971) in conjunction with the EVAT unless a patient requires a diagnostic extremity Doppler ultrasound on the same day as the EVAT, in which case a modifier should be used to signify the provision of a separate and distinct service. 


For evaluation of extremity veins for venous incompetence or deep vein thrombosis, use CPT codes 93970, duplex scan of extremity veins; complete bilateral study or 93971, unilateral or limited study. Medicare has created code G0365 to be used for vessel mapping performed in conjunction with the creation of an autogenous hstula for hemodialysis access. The code includes evaluation of  the relevant arterial and venous vessels. 


The limited venous extremity code (93971) is used for all other vein mapping. Check with your payers for coverage guidelines on this procedure. In some cases it is not paid in the absence of a previous condition such as severe varicose veins or previous deep vein thrombosis.

The following CPT codes are used to describe saphenous vein ablation procedures using the radiofrequency and laser methods: 36475, +36476, 36478 and +36479. The new codes are inclusive of all imaging guidance; ultrasound guidance of these procedures is not separately reportable. Although carrier policies vary, typically, preoperative extremity duplex to identify and characterize the venous incompetence can still be reported separately. 


The recommended codes for that procedure are 93970 and 93971 - Duplex scan of extremity veins, depending upon whether the study is complete and bilateral or limited and unilateral.

When spectral and color Doppler evaluation of the extremities is performed, use the appropriate code (93925-93926, 93930-93931, 93970 or 93971) in conjunction with 76881 or 76882.

• DVT:

- Two-point compression ultrasound of the lower extremity to evaluate for DVT would be coded by a limited duplex scan of the extremity veins (93971-26).


Focused DVT study 93971 Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study 

Medicare does not pay separately for this service. CPT CODE 93965

Billing for monitoring of hemodialysis access using CPT codes for noninvasive vascular studies other than 93990 is considered a misrepresentation of the service actually provided and contractors will consider this action for fraud investigation. They will conduct data analysis on a periodic basis for noninvasive diagnostic studies of the extremities (including CPT codes 93922, 93923, 93924, 93925, 93926, 93930, 93931, 93965, 93970, 93971). 

Contractors should handle aberrant findings under normal program safeguard processes by taking whatever corrective action is deemed necessary  .

Indications

Indications for venous examinations are separated into the following categories: deep vein thrombosis (DVT), chronic venous insufficiency, and preoperative venous mapping .

A physiologic study implies functional measurement procedures including Doppler ultrasound studies, blood pressure measurements, transcutaneous oxygen tension measurements, or plethysmography.

Plethysmography implies volume measurement procedures including air, impedance, or strain gauge methods.

Acceptable Procedures for Reimbursement

Duplex scan (CPT/HCPCS codes 93970, 93971, G0365) Doppler waveform analysis including responses to compressions and other maneuvers (CPT code 93965) Impedance Plethysmography (CPT code 93965)

Billing Guide for G0365


Medicare has created code G0365 to be used for vessel mapping performed in conjunction with the creation of an autogenous hstula for hemodialysis access. The code includes evaluation of the relevant arterial and venous vessels. The limited venous extremity code (93971) is used for all other vein mapping. Check with your payers for coverage guidelines on this procedure. In some cases it is not paid in the absence of a previous condition such as severe varicose veins or previous deep vein thrombosis.


To evaluate the functioning of an existing hemodialysis graft or fistula, use CPT code 93990. Medicare has published specific coverage guidelines for this procedure - review the Local Coverage Determination for specifics.


G0365    Vessel mapping of vessels for hemodialysis access (Services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) $203.38‡ $12.54 $190.84‡ 0267 $190.84


Most contractors cover G0365 for diagnoses of renal failure and/or preoperative examination (V72.83)

Pre-operative examination for potential harvest vein grafts or pre-operative examination of vessel prior to hemodialysis access surgery Z01.818. For codes in the table below that require a 7th character, letter A initial encounter, D subsequent encounter or S sequela may be used. 


Coding Guidelines


1. Use the appropriate procedure code and modifiers.


2. Indicate the diagnoses for which the testing is being performed.


3. No paper documentation is required on initial claims submission unless required by an audit or the case deserves special case-by-case review. 


Place information on claim form as EMC narrative where indicated in the policy, e.g., follow-up

studies.

4. Upper and lower extremity physiologic studies (CPT-4 codes 93922 and 93923), Lower extremity studies (CPT-4 codes 93925 and 93926), and Upper extremity duplex studies (CPT-4 codes 93930 and 93931)


If studies are performed on the upper and lower extremities on the same day, the services should be submitted on separate detail lines. When claims are submitted electronically, it should be indicated in Item19 of field N-4 (old format) or in record HAO-05 of the National Standard format, that upper AND lower studies were performed. If paper claims are still being submitted, this information must appear on the CMS-1500 claim form. 


5. We will not permit separate payment for CPT code 93971 when G0365 is billed, unless CPT code 93971 is being performed for a separately identifiable indication in a different anatomic region. Other imaging studies may not be billed for the same site on the same date of service unless an appropriate “KX” modifier indicating the reason or need for the second imaging study is provided on the claim form.  

Supervision:


General Supervision is defined as: "The procedure is furnished under the physician's overall direction and control, but the physician's presence is not required during the performance of the procedure. Under general supervision, the training of the non-physician personnel who actually performs the diagnostic procedure and the maintenance of the necessary equipment and supplies are the continuing responsibility of the physician." (PM B-01-28, April 29, 2001)


CMS has determined the following list of procedures require general physician supervision effective July 1 2001:


93875 & TC, 93880 & TC, 93882 & TC, 93886 & TC, 93888 & TC, 93922 & TC, 93923 & TC, 93924 & TC, 93925 & TC, 93926 & TC, 93930 & TC, 93965 & TC, 93970 & TC, 93971 & TC (PM B-01-28, April 19, 2001) 

 We will not permit separate payment for CPT code 93971 when G0365 is billed, unless CPT code 93971 is being performed for a separately identifiable indication in a different anatomic region.

Other imaging studies may not be billed for the same site on the same date of service unless an appropriate “KX” modifier indicating the reason or need for the second imaging study is provided on the claim form. 


Definitions


    A duplex scan is an ultrasonic scanning procedure with display of both two-dimensional structure and motion with time and Doppler ultrasonic signal documentation with spectral analysis and/or color flow velocity mapping or imaging.


    Noninvasive physiologic studies are performed using equipment separate and distinct from the duplex scanner. Physiologic studies are functional measurement procedures that include Doppler ultrasound studies, blood pressure measurements, transcutaneous oxygen tension measurements or plethysmography. A complete extremity physiologic study includes pressure measurements and an additional physiologic technique, e.g., Doppler ultrasound study or plethysmography.


    Plethysmography implies volume measurement procedures including air impedance or strain gauge methods. Plethysmography involves the measurement and recording (by one of several methods) of changes in the size of a body part as modified by the circulation of blood in that part.


    Indications


    Non-invasive evaluation of extremity veins will be considered to be medically necessary under any of the following circumstances:


 • The patient has deep venous thrombophlebitis or has clinical findings (otherwise unexplained limb pain, swelling) which suggest the possibility of acute deep venous thrombophlebitis.

 • The patient presents with signs and symptoms of pulmonary embolism (PE) indicated by dyspnea, chest pain, and/or hemopytsis.
  • The patient has acute pulmonary embolism.
 • Evaluation of patient with symptomatic varicose veins such as stasis ulcer of the lower leg, significant pain and significant edema that interferes with activities of daily living that have not resolved following three months of conservative therapy, and symptoms are suspected to be secondary to venous insufficiency, and testing is performed to confirm this diagnosis by documenting venous valvular incompetence prior to an invasive therapeutic intervention, which meets criteria for medical necessity as outlined in the LCD for Treatment of varicose veins of the lower extremity.
 • The patient has chronic venous insufficiency, post phlebitic syndrome, or lymphedema.
  • The patient has sustained trauma and injury of the venous system is suspected, making evaluation of the venous system of extremities necessary.
 • Venous mapping for the selection of a vein suitable for creating a dialysis fistula or prior to revascularization.
• Evaluation of possible venous obstruction or thrombosis in hospitalized patients who have recently undergone procedures, which predispose them to thrombosis and who would not have been therapeutically anti-coagulated otherwise (eg, hip replacements, knee replacements).

    Venous mapping is not always indicated as a routine pre-operative study. However, this procedure may be useful prior to surgical revascularization or creation of a dialysis fistula as part of the patient’s clinical evaluation in determination of an adequate venous conduit


Limitations

    Performance of both physiological testing (CPT code 93965) and duplex scanning (CPT codes 93970 or 93971) of extremity veins during the same encounter is not appropriate as a general practice or standing protocol, and therefore, would not generally be expected (American College of Radiology). Consequently, documentation must clearly support the medical necessity if both procedures are performed during the same encounter, and be available upon request. Note: Reimbursement of physiologic testing will not be allowed after a duplex scanning has been performed.

    Since the signs and symptoms of arterial occlusive disease and venous disease are so divergent, the performance of simultaneous arterial and venous studies during the same encounter should be rare. Consequently, documentation must clearly support the medical necessity of both procedures if performed during the same encounter, and be available upon request.


    Non-invasive vascular studies are considered medically necessary only if the outcome will potentially impact the clinical course of the patient. For example, if a patient is (or is not) proceeding on to other diagnostic and/or therapeutic procedures regardless of the outcome of non-invasive studies, and non-invasive vascular procedures will not provide any unique diagnostic information that would impact patient management, then the non-invasive procedures are not medically necessary. If it is obvious from the findings of the history and physical examination that the patient is going to proceed to angiography, then non-invasive vascular studies are not medically necessary.


    Performance of both non-invasive extracranial arterial studies (CPT codes 93880 or 93882) and non-invasive evaluation of extremity veins (CPT codes 93965, 93970 or 93971) during the same encounter is not appropriate as a general practice or standing protocol, and therefore, would not generally be expected (American College of Radiology, 2010). Consequently, documentation must clearly support the medical necessity if both procedures are performed during the same encounter, and be available upon request.]


    When an uninterpretable study results in performing another type of study, only the successful study should be billed. For example, when an uninterpretable non-invasive physiologic study (CPT code 93965) is performed which results in performing a duplex scan (CPT codes 93970 or 93971), only the duplex scan should be billed.


    It is not considered medically reasonable and necessary to study asymptomatic varicose veins.


Methods Not Acceptable for Reimbursement


    The following methods are not covered per CMS Manual System, Pub 100-03, Medicare National Coverage Determinations, Chapter 1, Section 20.14 as these methods have not yet reached a level of development such as to allow their routine use in the evaluation of suspected peripheral vascular disease.


    • Inductance Plethysmography

    • Capacitance Plethysmography
    • Mechanical Oscillometry
    • Photoelectric Plethysmography

ICD-10 Codes that Support Medical Necessity

    
  I26.01 Septic pulmonary embolism with acute cor pulmonale
  I26.02 Saddle embolus of pulmonary artery with acute cor pulmonale
  I26.09 Other pulmonary embolism with acute cor pulmonale
  I26.90 Septic pulmonary embolism without acute cor pulmonale
 I26.92 Saddle embolus of pulmonary artery without acute cor pulmonale
  I26.99 Other pulmonary embolism without acute cor pulmonale
  I48.0 Paroxysmal atrial fibrillation
  I48.2 Chronic atrial fibrillation
  I48.91 Unspecified atrial fibrillation
 180.00 Phlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity
  I80.01 Phlebitis and thrombophlebitis of superficial vessels of right lower extremity
  I80.02 Phlebitis and thrombophlebitis of superficial vessels of left lower extremity
   I80.03 Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral
    I80.10 Phlebitis and thrombophlebitis of unspecified femoral vein
    I80.11 Phlebitis and thrombophlebitis of right femoral vein
    I80.12 Phlebitis and thrombophlebitis of left femoral vein
    I80.13 Phlebitis and thrombophlebitis of femoral vein, bilateral
    I80.201 Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity
    I80.202 Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity
    I80.203 Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral
    I80.209 Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity
    I80.211 Phlebitis and thrombophlebitis of right iliac vein
    I80.212 Phlebitis and thrombophlebitis of left iliac vein
    I80.213 Phlebitis and thrombophlebitis of iliac vein, bilateral
    I80.219 Phlebitis and thrombophlebitis of unspecified iliac vein
    I80.221 Phlebitis and thrombophlebitis of right popliteal vein
    I80.222 Phlebitis and thrombophlebitis of left popliteal vein
    I80.223 Phlebitis and thrombophlebitis of popliteal vein, bilateral
    I80.229 Phlebitis and thrombophlebitis of unspecified popliteal vein
    I80.231 Phlebitis and thrombophlebitis of right tibial vein
    I80.232 Phlebitis and thrombophlebitis of left tibial vein
    I80.233 Phlebitis and thrombophlebitis of tibial vein, bilateral
    I80.239 Phlebitis and thrombophlebitis of unspecified tibial vein
    I80.291 Phlebitis and thrombophlebitis of other deep vessels of right lower extremity
    I80.292 Phlebitis and thrombophlebitis of other deep vessels of left lower extremity
    I80.293 Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral
    I80.299 Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity
    I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified
    I80.8 Phlebitis and thrombophlebitis of other sites
    I82.401 Acute embolism and thrombosis of unspecified deep veins of right lower extremity
    I82.402 Acute embolism and thrombosis of unspecified deep veins of left lower extremity
    I82.403 Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral
    I82.409 Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity
    I82.411 Acute embolism and thrombosis of right femoral vein
    I82.412 Acute embolism and thrombosis of left femoral vein
    I82.413 Acute embolism and thrombosis of femoral vein, bilateral
    I82.419 Acute embolism and thrombosis of unspecified femoral vein
    I82.421 Acute embolism and thrombosis of right iliac vein
    I82.422 Acute embolism and thrombosis of left iliac vein
    I82.423 Acute embolism and thrombosis of iliac vein, bilateral
    I82.429 Acute embolism and thrombosis of unspecified iliac vein
    I82.431 Acute embolism and thrombosis of right popliteal vein
    I82.432 Acute embolism and thrombosis of left popliteal vein
    I82.433 Acute embolism and thrombosis of popliteal vein, bilateral
    I82.439 Acute embolism and thrombosis of unspecified popliteal vein
    I82.441 Acute embolism and thrombosis of right tibial vein
    I82.442 Acute embolism and thrombosis of left tibial vein
    I82.443 Acute embolism and thrombosis of tibial vein, bilateral
    I82.449 Acute embolism and thrombosis of unspecified tibial vein
    I82.491 Acute embolism and thrombosis of other specified deep vein of right lower extremity
    I82.492 Acute embolism and thrombosis of other specified deep vein of left lower extremity
    I82.493 Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral
    I82.499 Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity
    I82.4Y1 Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity
    I82.4Y2 Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity
    I82.4Y3 Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral
    I82.4Y9 Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity
    I82.4Z1 Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity
    I82.4Z2 Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity
    I82.4Z3 Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral
    I82.4Z9 Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity
    I82.501 Chronic embolism and thrombosis of unspecified deep veins of right lower extremity
    I82.502 Chronic embolism and thrombosis of unspecified deep veins of left lower extremity
    I82.503 Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral
    I82.509 Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity
    I82.511 Chronic embolism and thrombosis of right femoral vein
    I82.512 Chronic embolism and thrombosis of left femoral vein
    I82.513 Chronic embolism and thrombosis of femoral vein, bilateral
    I82.519 Chronic embolism and thrombosis of unspecified femoral vein
    I82.521 Chronic embolism and thrombosis of right iliac vein
    I82.522 Chronic embolism and thrombosis of left iliac vein
    I82.523 Chronic embolism and thrombosis of iliac vein, bilateral
    I82.529 Chronic embolism and thrombosis of unspecified iliac vein
    I82.531 Chronic embolism and thrombosis of right popliteal vein
    I82.532 Chronic embolism and thrombosis of left popliteal vein
    I82.533 Chronic embolism and thrombosis of popliteal vein, bilateral
    I82.539 Chronic embolism and thrombosis of unspecified popliteal vein
    I82.541 Chronic embolism and thrombosis of right tibial vein
    I82.542 Chronic embolism and thrombosis of left tibial vein
    I82.543 Chronic embolism and thrombosis of tibial vein, bilateral

    I82.549 Chronic embolism and thrombosis of unspecified tibial vein
many more

ICD-9-CM Codes that Support Medical Necessity
The CPT/HCPCS codes included in this policy will be subjected to “procedure to diagnosis” editing. The following lists include only those diagnoses for which the identified CPT/HCPCS procedures are covered. If a covered diagnosis is not on the claim, the edit will automatically deny the service as not medically necessary.
Medicare is establishing the following limited coverage for HCPCS/CPT codes 93965, 93970, 93971 and G0365:

Covered for:
410.00–410.02  Acute myocardial infarction of anterolateral wall
410.10–410.12 Acute myocardial infarction of other anterolateral wall
410.20–410.22 Acute myocardial infarction of inferolateral wall
410.30–410.32 Acute myocardial infarction of inferoposterior wall
410.40–410.42 Acute myocardial infarction of other inferior wall
410.50–410.52 Acute myocardial infarction of other lateral wall
410.60–410.62 Acute myocardial infarction, true posterior wall infarction
410.70–410.72 Acute myocardial infarction, subendocardial infarction
410.80–410.82 Acute myocardial infarction, other specified sites
411.0–411.1 Other acute and subacute forms of ischemic heart disease
411.81 Acute coronary occlusion without myocardial infarction
411.89 Other acute and subacute forms of ischemic heart disease, other
412 Old myocardial infarction
413.0–413.1 Angina pectoris
414.00–414.07 begin_of_the_skype_highlighting           
 00–414.07      end_of_the_skype_highlighting Coronary atherosclerosis
414.10–414.12 Aneurysm and dissection of heart
414.8 Other specified forms of chronic ischemic heart disease
415.0 Acute cor pulmonale
415.11–415.12 Pulmonary embolism and infarction
415.19 Other pulmonary embolism and infarction
440.0–440.1 Atherosclerosis
440.20–440.24 Atherosclerosis of native arteries of the extremities
440.29 Other atherosclerosis of native arteries of the extremities
440.30–440.32 Atherosclerosis of bypass graft of the extremities
444.22 Arterial embolism and thrombosis of lower extremity
444.9 Arterial embolism and thrombosis of unspecified artery
Note: Use code 444.9 only for paradoxical embolism.
451.0  Phlebitis and thrombophlebitis of superficial vessels of lower extremities
451.11 Phlebitis and thrombophlebitis of femoral vein
451.19 Phlebitis and thrombophlebitis of other vein, i.e., tibial, popliteal and femoropopliteal
451.2 Phlebitis and thrombophlebitis of lower extremities, unspecified
451.81–451.84 Phlebitis and thrombophlebitis, of other sites
451.89 Phlebitis and thrombophlebitis, other
451.9 Phlebitis and thrombophlebitis of unspecified site
453.2 Embolism and thrombosis of inferior vena cava
453.40–453.42 Venous embolism and thrombosis of deep vessels of lower extremity
453.50–453.52 Chronic venous embolism and thrombosis of deep vessels of lower extremity
453.6 Venous embolism and thrombosis of superficial vessels of lower extremity
453.72–453.76 Chronic venous embolism and thrombosis of other specified vessels
453.79 Chronic venous embolism and thrombosis of other specified veins
453.82–453.86 Acute venous embolism and thrombosis of other specified veins
453.89 Acute venous embolism and thrombosis of other specified veins
454.0–454.2 Varicose vein of lower extremities
454.8 Varicose vein of lower extremities, with other complications
459.10–459.13 Post-phlebitic syndrome
459.19 Post-phlebitic syndrome, with other complication
459.2 Compression of vein
459.30–459.33 Chronic venous hypertension (idiopathic)
459.39 Chronic venous hypertension (idiopathic), with other complications
518.81 Acute respiratory failure
585.3–585.6 Chronic kidney disease (CKD)
671.02 Varicose veins of legs with delivery with postpartum complication
671.20–671.24 Venous complications in pregnancy and the puerperium, superficial thrombophlebitis
671.30–671.31 Venous complications in pregnancy and the puerperium, deep phlebothrombosis, antepartum
671.33  Venous complications in pregnancy and the puerperium, deep phlebothrombosis, antepartum condition or complication

Documentation Requirements
  • Documentation supporting the medical necessity should be legible, maintained in the patient's medical record and made available to Medicare upon request.
  • In the case of vascular studies and their interpretations, a hard copy (or a soft copy convertible to a hard copy) must be maintained as a permanent record of the study performed and must be of a quality that meets accepted radiologic standards.
  • Medical necessity for performance of simultaneous arterial and venous studies should be rare. Subsequently, documentation must clearly support the reasonableness and medical necessity for both procedures performed during the same encounter.

Non-Coronary Vascular Stents CPT 37205, 37227, 75960
Vascular stents are used to enhance primary patency in arteries and veins, usually at the site of stenotic or occlusive lesions. Stents also may be used as an adjunct to technically inadequate Percutaneous Transluminal Angioplasty (PTA) or in cases where PTA alone will not be expected to provide a durable result. Peripheral vascular stenting may be indicated for patients with symptomatic arterial and venous disease resulting in an occlusive process.
Appropriate symptoms at the designated vascular sites include:
  • Renal artery. This includes: renovascular hypertension (see “Renal Arteries” section below) and insufficiency; mesenteric ischemia; post-transplant renal, pancreatic or hepatic ischemia; or arterial dissection. Stenting of renal arteries is covered only when angioplasty of the vessel would not suffice and after the patient has had a thorough medical evaluation and management of symptoms, and for whom surgical intervention is the likely alternative. In these situations, PTA and stent placement should be considered an alternative to surgery and not an addition to medical management.
  • Lower extremity arteries (abdominal aorta, iliac, superficial femoral, subpopliteal arteries). This includes: lifestyle-limiting claudication, focal hemodynamically significant lesion, ischemic rest pain, non-healing tissue ulceration and focal gangrene. Peripheral vascular stenting is covered for symptomatic patients with occlusive disease of the arterial or venous system. Vascular stents are utilized either following a suboptimal or failed PTA, or as a planned adjunct to PTA (so-called primary stenting). When PTA of the vessel without stenting is not expected to or has not been sufficient to restore sufficient blood flow in symptomatic patients for whom surgery is the likely alternative, PTA with stent placement is indicated as an alternative to surgery – not simply an addition to medical management.
  • Hemodialysis access graft/fistula. This includes: stenosis, restenosis and occlusion.
  • Superior vena cava. This includes: superior vena cava syndrome, post-radiation venous stenosis and congenital stenosis.
  • Brachiocephalic arteries. This includes: subclavian steal syndrome, upper extremity claudication, ischemic rest pain of the arm and hand, non-healing tissue ulceration and focal gangrene.
  • Iliac veins and inferior vena cava. Stenting in these areas should be rare and would be considered at the review level with supporting documentation.
  • Venous occlusive disease. This includes: superior vena cava syndrome, venous occlusions and stenoses, post-radiation venous stenosis, congenital stenoses or webs, extrinsic venous compression (iliac artery compression syndrome - May Thurner syndrome) and symptomatic post-traumatic venous stenosis.
  • Mesenteric vessels. This includes acute mesenteric ischemia, chronic mesenteric ischemia, mesenteric thrombosis, dissection or any other vascular insufficiency resulting in gastrointestinal symptoms; stenting of the mesenteric vessels is covered only when angioplasty of the vessels would not suffice and after the patient has had a thorough medical evaluation and management of symptoms, and for whom surgical intervention is the likely alternative. The eligible patients will have multiple comorbidities making them poor candidates for open surgical procedures. In these situations, PTA and stent placement should be considered an alternative to surgery and not an addition to medical management.
Coverage for the above indications for non-coronary vascular stents depends on the use of an FDA-approved stent. Several different stents are currently used in the medical community. Each device has specific indications described by the FDA for approved market uses. Stent placement is covered by Medicare only when an FDA-approved stent is:
  • Used for the FDA-approved indications;
Or,
  • Used for the above indications supported by the peer medical literature.
Vascular stents are deployed as a planned adjunct or alternative to PTA or following suboptimal or failed PTA. Medical documentation for both circumstances is necessary. A suboptimal or failed PTA is defined as a dilation judged by the physician to be suboptimal or failed due to the presence of unfavorable lesion morphology such as:
  • An inadequate angiographic and/or hemodynamic result as defined by a 30 percent or greater residual stenosis post-PTA, lesion recoil or intimal flaps.
  • Flow limiting dissections post-PTA.
  • A 5 mm Hg or greater mean trans-stenotic pressure gradient post-PTA.
  • Acute occlusion of the vessel post-PTA.
  • Significant recurrence of a lesion at the prior PTA site within 12 months.
A stent may be placed as a planned adjunct to PTA rather than in response to a suboptimal or failed PTA (so-called primary stent deployment). Primary stenting is justified for situations where PTA alone is not expected to provide a durable result such as:
  • Arterial or venous occlusions that carry a high risk for distal embolization or rapid recurrence.
  • Occlusive lesions known to be unfavorable for PTA alone, such as significantly calcified lesions, eccentric lesions, lesions related to external compression (e.g., May-Thurner syndrome and malignant compression of the superior vena cava) or ostial renal artery stenoses.
Renal Arteries
Renal artery angioplasty meets coverage criteria for patients with uncontrolled hypertension (diastolic blood pressure > 100 mm Hg on two antihypertensive drugs) who have been found to have unilateral or bilateral renal artery stenosis = 50 percent by nuclear medicine studies, renal artery duplex Doppler or renal arteriography. Stenting meets coverage criteria for ostial lesions, for angioplasty with suboptimal results and for dissection. For patients with renal artery stenosis of < 50 percent, and suspected renovascular hypertension, coverage criteria are met if renal vein renin studies indicate the hypertension is due to renal artery disease.

Renal artery angioplasty meets coverage criteria for patients with rapidly progressive renal insufficiency due to atherosclerotic stenosis of = 75 percent obstruction. Stenting meets coverage criteria for ostial lesions, for angioplasty with suboptimal results and dissection.

Renal artery angioplasty meets coverage criteria for patients with recurrent acute pulmonary edema without cardiac cause, who have stenosis of the renal artery(s) of = 60 percent. Stenting meets coverage criteria for ostial lesions, angioplasty with suboptimal results and dissection.

Renal artery angioplasty meets coverage criteria for patients with renal artery stenosis of = 50 percent in a transplanted kidney. Stenting meets coverage criteria for ostial lesions, angioplasty with suboptimal results and dissection.

Renal artery angioplasty with or without stenting does not meet coverage criteria for patients with renal artery atherosclerosis or stenosis but who do not have any of the conditions mentioned above.

Sequential Procedures
Vascular obstructions may be caused by thrombosis, embolism, atherosclerosis or other conditions and may be multifocal in a single vascular family or in multiple vascular families. Management options to maintain or re-establish the patency of a vessel in a particular vascular family include surgery, thrombectomy,
embolectomy, endarterectomy, thrombolysis, atherectomy, angioplasty and stent placement. These procedures may be performed alone or in sequence. The initial procedure may be followed at the same encounter by a sequential, usually “more invasive,” procedure. There may be separate CPT /HCPCS codes describing each service. The subsequent procedure(s) is necessary because the initial approach was unsuccessful or only partially successful in accomplishing the intended goal (that is, to maintain or re-establish the patency of a vessel). An example of this situation is when an atherectomy is followed by an angioplasty and the angioplasty followed by the placement of a stent.
Limitations
  1. The placement of a stent in a vessel for which there is no objective-related symptom or limitation of function is considered to be preventive and, therefore, not covered by Medicare.
  2. Use of non-coronary vascular stents is covered only after the patient has had a thorough evaluation and treatment of symptoms and when PTA of the vessel alone has not, or is not expected to, sufficiently resolve the symptoms making surgery the likely alternative.
  3. A non-coronary intravascular stent(s) that carries an Investigational Device Exemption (IDE) may be covered under Medicare. Medicare coverage of IDE devices is predicated, in part, upon their status with the FDA. Payment will cease in the event a manufacturer loses its (or violates relevant IDE requirements necessitating FDA’s withdrawal of) IDE approval. The FDA issues a special identifier number that corresponds to each device or stent(s) granted an IDE.
Note: Requirements for payment of an IDE can be found on the TrailBlazer Web site at:http://www.trailblazerhealth.com/Policies/Devices/Default.aspx?DomainID=1
Notice: This LCD imposes diagnosis limitations that support diagnosis to procedure code automated denials. However, services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.
As published in CMS IOM 100-08, Section 13.5.1, to be covered under Medicare, a service shall be reasonable and necessary. When appropriate, contractors shall describe the circumstances under which the proposed LCD for the service is considered reasonable and necessary under Section 1862(a)(1)(A). Contractors shall consider a service to be reasonable and necessary if the contractor determines that the service is:
  • Safe and effective.
  • Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
  • Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
    • Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
    • Furnished in a setting appropriate to the patient’s medical needs and condition.
    • Ordered and furnished by qualified personnel.
    • One that meets, but does not exceed, the patient’s medical need.
    • At least as beneficial as an existing and available medically appropriate alternative.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.
12X, 13X, 85X
Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.
Note: TrailBlazer has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this LCD. Providers are reminded that not all CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS Internet-Only Manual Publication 100-04, Claims Processing Manual, for further guidance.
0320, 0323, 0329, 0340, 0342, 0349, 035X, 0402, 0404, 0409, 0610, 0614, 0615, 0616, 0618, 0619

Popular Posts